Blue Owl Co-CEOs Remove Share Loans to Ease Stock Pressure
CEOs removed risky share-backed loans, easing fears, as investors worry about private credit and withdrawals.
Already have an account? Sign in.
CEOs removed risky share-backed loans, easing fears, as investors worry about private credit and withdrawals.
DOJ may sue Cal-Maine Foods and Versova for possibly coordinating to keep egg prices high during bird flu shortages.
Cerebras plans a Nasdaq IPO after strong growth, big AI deals, and rising demand for powerful chips competing with Nvidia.
UBS starts coverage on Amneal Pharmaceuticals with a Buy rating. Strong specialty growth, Parkinson’s drugs, and attractive entry point after recent selloff.